期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

辛伐他汀联合依折麦布对冠心病患者血脂及血清C-反应蛋白的影响 被引量：3

原文传递
导出
摘要 他汀类药物除调脂外,尚且有抑制平滑肌细胞的增生和移动,改善血管内皮功能,抑制新生血管的生成等作用,并有很强的对抗炎症反应的作用。我们探讨辛伐他汀联合依折麦布对冠心病患者血脂及血清C-反应蛋白水平的影响。
作者 叶达平 时霞飞 王宏俊
机构地区 南京市浦口区中心医院心脏病科
出处 《江苏医药》 CAS CSCD 北大核心 2011年第11期1352-1353,共2页 Jiangsu Medical Journal
关键词 血清C-反应蛋白 冠心病患者 依折麦布 辛伐他汀 血脂 血管内皮功能 他汀类药物 平滑肌细胞
分类号 R730.3 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1彭晓玲,林泽鹏,张志伟,赵有生,秦迁.辛伐他汀、卡维地洛单用及合用对老年高血压伴心衰患者心室重构及心功能的影响及其机制探讨[J].南方医科大学学报,2008,28(3):422-424. 被引量：19
  • 2Sudhop T, Lutjohann D, Bergmann K, et al. Inhibition of intes final cholesterolabsorption by ezetimibe in humans[J]. Circulation, 2002, 106(15) : 1943-1948.
  • 3Kastelein JP, Akdim F, Stroes ESG, et al. Simvastatin with or without Ezetimibe in familial hypercholesterolemia[J]. N Engl J Med, 2008,358 (14): 1431-1443.
  • 4Miura S, Saku K. Beneficial effects of ezetimibe hased therapy in patients with dyslipidemia[J]. J Cardiol, 2008,52(1) : 1-6.
  • 5McCormack T, Harvey P, Gaunt R, et al. Incremental cholesterol reduction with ezetirnibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of joint british societies (JBS-2) cholesterol targets(JBS-2) cholesterol targets[J]. Int J Clin Pract,2010,64(8) : 1006.
  • 6Pearson TA, Ballaneyne CM, Vehri E, et al. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy[J]. Am J Cardiol, 2009,103 (3) : 369.

二级参考文献7

  • 1李为民,孔一慧.他汀类药物治疗慢性心力衰竭的利弊探讨[J].中华心血管病杂志,2006,34(9):774-775. 被引量：28
  • 2Corsini A. Fluvastatin: effects beyond cholesterol lowering [J]. J Cardiovasc Pharmacol Tiler, 2005, 5: 161-75.
  • 3Trochu JN, Mital S, Zhang X, et al. Preservation of NO production by statins in the treatment of heart failure[J]. Cardiovasc Res, 2003, 60: 250-58.
  • 4Reinhard D, Sigusch HH, Hensse J, et al. Cardiac remodeling in end stage heart failure:upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP[J]. Heart, 2002, 88:525 -30.
  • 5Aikawa M, Ribkin E, Sugyama S, et al. An H mg-Coa reductage inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro[J]. Circulation, 2001, 103: 276-83.
  • 6Grip O, Janciauskiene S, Lindgren S. Pravastatin down-regulates inflammatory mediators in human monocytes in vitro [ J ]. Eur J Pharmacol, 2000, 410: 83-92.
  • 7Stephen C, Harrihar A, Christopher I, et al. Identification of telmisartan as a unique angiotensin Ⅱ receptor antagonist with selective PPARγ-modulating activity [J ]. Hypertention, 2004, 43: 993-1002.

共引文献18

同被引文献36

  • 1顾萍,缪东培.他汀类药物防治脑卒中的进展[J].医学研究生学报,2005,18(3):262-265. 被引量：4
  • 2郭建浩,陈耀强,邓宁星,陈若峰,周慧.阿托伐他汀对不稳定型心绞痛患者C-反应蛋白的影响[J].中国心血管病研究,2005,3(11):830-831. 被引量：5
  • 3高海青.第二次中国临床血脂控制状况多中心协作暨REALITY研究[J].华夏医药,2007,2(2):117-124. 被引量：16
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2140
  • 5Debacker J,Mak R,Debacquer D,et al. Parameters of inflamma-tion and infection in a communitybased case control study of coro-nary heart disease. Atherosclerosis,2002,160 (2) :457-463.
  • 6Huittine T,Leinonenm M,Tenkanen L,et al. Synergistic effect ofpersistent Chlamydia pneumoniae infection, autoimmunity, and in-flammation on coronary risk. Circulation, 2003,107 ( 20) :2566-2570.
  • 7Miller M. Lipid levels in the post-acute coronary syndrome set-ting :destabilizing another myth.. J Am Coll Cardiol, 2008, 51(15):1446-1447.
  • 8Ridker PM. Clinical application of C-reactive protein for cardio-vascular disease detection and prevention. Circulation, 2003,107(3):363.
  • 9Patrik JE, Kosoglou T, Stauber KL, et al. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects[J]. Drug Metab Dispos, 2002,30(4) : 430-437.
  • 10Radakrishnamurthy B, Sharma C, Bhandaru RR, et al. Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycolsaminoglycan [J ]. Atherosclerosis, 1986, 60(2) :141-149.

二级引证文献18

江苏医药
2011年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部